Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | PYGB | P11216 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8864496 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL8886001 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL7804811 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL8864313 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL15553441 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL8864825 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL8864263 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL8864783 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL8864165 | 0.95 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 | |
| SCHEMBL15232781 | 0.92 | MAPK1 (0.38) | MAPK1GBA1ADORA2AADORA2BCDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140370098-A1 | TINTED EMULSION | L'OREAL (FR) | 2014-12-18 | — | — | US | disclosed |
| EP-2782553-A1 | TINTED EMULSION | L'Oréal (FR) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013076691-A1 | TINTED EMULSION | L'OREAL (FR) | 2013-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140370098-A1 | TINTED EMULSION | KRT18, LAGE3, DSG1 | MAPK1 3958/4885GBA1 3779/4885ADORA2A 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.